Mouse Irak3/4833428C18Rik/AI563835 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_028679)
Cat. No.: pGMAAV000125
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Mouse Irak3/4833428C18Rik/AI563835 Adeno-associated virus expression plasmid (ITR-vector) for Irak3 AAV packaging, Irak3 AAV production.The purified Mouse Irak3/4833428C18Rik/AI563835 AAV particle serves as an invaluable asset for in-depth in vivo Irak3 studies, mechanism of action (MOA) research, and the evolution of Irak3-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Product Description
Catalog ID | pGMAAV000125 |
Gene Name | Irak3 |
Accession Number | NM_028679 |
Gene ID | 73914 |
Species | Mouse |
Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
Insert Length | 1830 bp |
Gene Alias | 4833428C18Rik,AI563835,IRAK-M |
Fluorescent Reporter | Null |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCCGGCCGGTGCGGGGCCCGTGGCGCGCTGTCGCCACAGTTGCTGCTCTTCGACCTGCCGCCCGCACTGCTGGGAGAGCTTTGCGGGATCCTGGACAGCTGCGATGGCCCGCTCGGCTGGCGGGGCCTGGCGGAGCGACTTTCAAACAGCTGGCTGGATGTTCGTCATATTGAAAAGTACGTAAACCAAGGTAAAAGTGGAACAAGAGAATTGCTCTGGTCCTGGGCACAGAAAAACAAGACGATCGGCGACCTTTTAGAGGTTCTCCAGGACATGGGGCATCAACGAGCTATCCACTTAATCATCAACTATGGAGTAAGCTGGACTCCTTCAGTGCAGACGCATCACGAGCTTCCATTCCCCAGCTTCCCACCTGAGGTGAAGCATGCGTGCAGAGAAAACGACCCTGGACCTCTGGAACCAGCCAATGTCACAGTGGATAATGTTCTTGTTCCTGAACATAATGAAAAAGGAACACTGCAGAAAACCCCTATCAGCTTCCAGAGTATCCTAGAAGGAACCAAACATTTCCACAAAGACTTCCTGATTGGAGAAGGGGAGATATTCGAAGTATACAGAGTGGACATTCGAAACCAAGCATATGCTGTTAAATTGTTTAAACAGGAGAAAAAAATGCAACTAAAGAAGCACTGGAAGAGATTTTTATCAGAACTGGAAGTTCTACTCCTGTTCCGTCACCCCCACATACTAGAGCTGGCTGCATATTTCACGGAGACTGAGAAACTTTGTCTGGTTTATCCCTATATGAGCAACGGGACGCTTTTCGACAGATTACAGTGCACAAATGGCACAACCCCGCTTTCCTGGCACGTTCGAATCAGCGTATTGATAGGAATAGCCAAAGCCATCCAATACTTGCACAACACTCAGCCGTGCGCCGTCATCTGTGGCAACGTTTCCAGTGCAAACATACTCTTGGATGACCAGCTCCAACCCAAACTAACGGATTTTGCTGCAGCGCACTTCCGACCCAATCTAGAGCAGCAGAGTTCTACCATAAATATGACCGGCGGTGGCAGGAAACATCTGTGGTACATGCCAGAAGAATACATCAGACAGGGAAGACTTTCCGTTAAAACTGATGTCTACAGCTTCGGAATCGTGATCATGGAGGTTCTAACGGGCTGCAAAGTGGTGCTGGATGACCCGAAACACGTTCAGCTGCGGGACCTCCTCATGGAACTGATGGAGAAAAGAGGCCTAGACTCCTGCCTGTCCTTCTTAGACAGGAAGATACCACCCTGTCCTCGGAACTTCTCTGCAAAGCTCTTCTCTCTGGCGGGCCGGTGTGTGGCAACGAAGGCCAAGTTAAGACCCACGATGGACGAAGTCCTGTCCTCTCTGGAGAGCACCCAGCCTAGCTTGTATTTTGCAGAAGACCCTCCCACGTCCTTGAAGTCCTTCAGGTGTCCTTCTCCACTGTTCTTGGATAATGTCCCAAGTATTCCAGTAGAAGATGATGAAAACCAGAATAACCATTCAGTACCTCCCAAGGAAGTTTTGGGGACAGATAGAGTGACTCAGAAAACCCCCTTTGAATGCAGCCAGTCTGAGGTCACCTTTCTAGGCTTGGACCGAAACAGAGGGAACAGGGGAAGTGAAGCGGATTGCAACGTGCCCAGTTCTTCTCATGAGGAATGCTGGTCCCCAGAGCTTGTGGCGCCATCCCAGGACTTAAGTCCTACTGTGATCAGTTTGGGCTCGTCTTGGGAAGTACCAGGCCATTCTTATGGGAGCAAGCCAATGGAGAAGAGGTGTTCCTCTGGGCTCTTTTGCAGTGAGCATGAACAGTCCAAAAAGCAGTGA |
ORF Protein Sequence | MAGRCGARGALSPQLLLFDLPPALLGELCGILDSCDGPLGWRGLAERLSNSWLDVRHIEKYVNQGKSGTRELLWSWAQKNKTIGDLLEVLQDMGHQRAIHLIINYGVSWTPSVQTHHELPFPSFPPEVKHACRENDPGPLEPANVTVDNVLVPEHNEKGTLQKTPISFQSILEGTKHFHKDFLIGEGEIFEVYRVDIRNQAYAVKLFKQEKKMQLKKHWKRFLSELEVLLLFRHPHILELAAYFTETEKLCLVYPYMSNGTLFDRLQCTNGTTPLSWHVRISVLIGIAKAIQYLHNTQPCAVICGNVSSANILLDDQLQPKLTDFAAAHFRPNLEQQSSTINMTGGGRKHLWYMPEEYIRQGRLSVKTDVYSFGIVIMEVLTGCKVVLDDPKHVQLRDLLMELMEKRGLDSCLSFLDRKIPPCPRNFSAKLFSLAGRCVATKAKLRPTMDEVLSSLESTQPSLYFAEDPPTSLKSFRCPSPLFLDNVPSIPVEDDENQNNHSVPPKEVLGTDRVTQKTPFECSQSEVTFLGLDRNRGNRGSEADCNVPSSSHEECWSPELVAPSQDLSPTVISLGSSWEVPGHSYGSKPMEKRCSSGLFCSEHEQSKKQ |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
ORF Viral Vector | vGMAAV000125 | Mouse Irak3 Adeno-associate virus(AAV) particle |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.